Seitzer, Jessica
University of Auckland · St George's, University of London · The Royal Free Hospital · Auckland City Hospital · Intellia Therapeutics (United States) · University College London
3 papers on CoChat
Most cited papers
- Verified
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., Seitzer, J., O’Connell, D., Walsh, K. R., Wood, K., et al. (2021) · New England Journal of Medicine
Amyloidosis: Diagnosis, Treatment, OutcomesCRISPR and Genetic Engineering
Cited by 1,801
- Verified
A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing
Finn, J. D., Smith, A. R., Patel, M. C., Shaw, L., Youniss, M. R., van Heteren, J., Dirstine, T., Ciullo, C., Lescarbeau, R., Seitzer, J., et al. (2018) · Cell Reports
RNA Interference and Gene DeliveryCRISPR and Genetic Engineering
Cited by 878
- Verified
Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment
Abrams, M. T., Koser, M. L., Seitzer, J., Williams, S. C., DiPietro, M. A., Wang, W., Shaw, A. W., Mao, X., Jadhav, V., Davide, J. P., et al. (2010) · Molecular Therapy
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 209
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free